Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of three clinical trials

  • Amy S. Paller*
  • , Elaine C Siegfried
  • , Michael J Cork
  • , Kenji Kabashima
  • , Peter Arkwright
  • , Edyta Gebska
  • , Zhen Chen
  • , Joseph Zahn
  • , Ana B. Rossi
    • *Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish
JournalJournal of the American Academy of Dermatology
Publication statusAccepted/In press - 6 May 2025

Keywords

  • atopic dermatitis
  • biomarkers
  • dupilumab
  • erythrodermic
  • pediatric eczema

    Embargoed Document

  • JAAD paper erythrodermic AD

    Accepted author manuscript, 4.08 MB

    Licence: CC BY

    Embargo ends: 13/05/26

Cite this